Loading...
Loading...
VAPO| Name | Value |
|---|---|
| Revenues | 16.9M |
| Cost of Revenue | 8.6M |
| Gross Profit | 8.3M |
| Operating Expense | 13.8M |
| Operating I/L | -9.3M |
| Other Income/Expense | -5.0M |
| Interest Income | 0.0M |
| Pretax | -14.3M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -14.3M |
Vapotherm, Inc. develops and sells proprietary high velocity therapy products for treating respiratory distress. Its precision flow systems, including Precision Flow Hi-VNI, deliver heated, humidified, and oxygenated air at high velocity through a nasal interface. The company also offers companion products such as Vapotherm Transfer Unit, Q50 compressor, and disposable patient circuits. Vapotherm's products are primarily sold to hospitals, providing a revenue stream through the sale of these medical devices and related accessories.
